Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology) - Image 1

£129.02

Springer Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Name: Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24-28, 1983: 23 (Developments in Oncology)
Brand: Springer
Price: 129.02 GBP
Availability: InStock

Prostate

It has never been this cheap. We have no record of a lower price.

£129 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days • 32 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 32 days • 1 price levels

Days at Price

Price Analysis

Most common price: £129 (32 days, 100.0%)

Price range: £129 - £129

Price levels: 1 different prices over 32 days

Description

Over the past 30 years many significant advances have been made in the management of a number of disseminated malignant diseases. The prognosis for diseases such as childhood leukaemia, choriocarcinoma and Hodgkin's disease has gradually been transformed as better anti tumour agents have become available and their clinical use has been refined. During the past 10 years the advent of new agents, particularly cisplatin, bleomycin and the podophyllotoxins, has allowed the cure of disseminated testicular tumours. This degree of success has not, however, been achieved in the case of a number of other common cancers. Ovarian carcinoma is tantalisingly chemo-sensitive and although there are long term survivors from disseminated disease, these are only a small proportion of the total. Breast cancer, although "sensitive" to a multitude of drugs appears to have yielded neither survival benefit, nor cure to the efforts of therapists, while tumours such as those of the colon remain stubbornly unresponsive. Against this backcloth it is apparent that additional more selective treatments are needed if further impact is to be made on the problem of cancer. The development of such agents requires the integration of a multidisciplinary effort encompassing the fields of chemistry, biology and medicine. This symposium provided a forum for clinical and preclinical sCientists, where current aspects of cancer treatment were reviewed and approaches to the development of a new generation of more selective anticancer drugs discussed.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461338395
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions > Prostate
Domain: Amazon UK
Publication Date: 17 October 2011
Listed Since: 21 December 2012

Barcode

No barcode data available

Springer Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Preoperative (Neoadjuvant) Chemotherapy: 103 (Recent Results in Cancer Research, 103)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Springer Cancer Chemotherapy Volume 36 - Research Series

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America: Volume 38-1 (The Clinics: Internal Medicine, Volume 38-1)

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias: 38 (Cancer Treatment and Research, 38)

Cancer Biology and Therapeutics

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Cancer Chemotherapy: Basic Science to the Clinic

Cancer Biology and Therapeutics

Evidence–Based Oncology (Evidence–Based Medicine)

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

The Chemistry of Antitumour Agents

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

UICC Manual of Clinical Oncology

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)